WASHINGTON, DC—Using an implantable cardiac monitor (ICM) to look for arrhythmias after an MI—and initiate treatment as appropriate—does not provide a significant clinical benefit, according to the ...

Please provide your email address to receive an email when new articles are posted on . Boston Scientific announced the FDA clearance of its next-generation insertable cardiac monitor for long-term ...

AT&T has inked a deal with eCardio Diagnostics to provide wireless connectivity to the arrhythmia monitoring company's near real-time cardiac monitoring devices. eCardio’s monitoring devices enable ...

Unobtrusive, Wireless System is User-Friendly to Support Patient Compliance SAN JOSE, Calif.-- Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received ...

iRhythm (IRTC) announced the results of five new studies presented at the American Heart Association’s 2024 Scientific Sessions in Chicago, IL. The five studies span three focus areas for long-term ...

SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC) (NASDAQ:IRTC) today announced the commercial launch in Japan of its Zio ® long-term continuous ECG monitoring (LTCM) ...

Please provide your email address to receive an email when new articles are posted on . Long-term continuous ECG monitoring with human oversight outperformed an artificial intelligence-based mobile ...

A new heart monitoring system combining 3D printing and artificial intelligence could transform the way doctors measure and diagnose patients' heart health. Developed at SFU's School of Mechatronic ...

Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented ...

iRhythm Technologies, Inc. (IRTC) has officially launched its Zio monitor and long-term continuous (LTCM) ECG monitoring service in Austria, the Netherlands, Spain and Switzerland. With CE mark ...